Carbapenem-Based Antibiotics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Carbapenem-Based Antibiotics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Carbapenem-Based Antibiotics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Carbapenem-Based Antibiotics Overall Market Size
2.1 Global Carbapenem-Based Antibiotics Market Size: 2022 VS 2032
2.2 Global Carbapenem-Based Antibiotics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Carbapenem-Based Antibiotics Players in Global Market
3.2 Top Global Carbapenem-Based Antibiotics Companies Ranked by Revenue
3.3 Global Carbapenem-Based Antibiotics Revenue by Companies
3.4 Top 3 and Top 5 Carbapenem-Based Antibiotics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Carbapenem-Based Antibiotics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Carbapenem-Based Antibiotics Players in Global Market
3.6.1 List of Global Tier 1 Carbapenem-Based Antibiotics Companies
3.6.2 List of Global Tier 2 and Tier 3 Carbapenem-Based Antibiotics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Carbapenem-Based Antibiotics Market Size Markets, 2022 & 2032
4.1.2 Meropenem
4.1.3 Doripenemu
4.1.4 Imipenem
4.1.5 Tebipenemu
4.1.6 Others
4.2 By Type - Global Carbapenem-Based Antibiotics Revenue & Forecasts
4.2.1 By Type - Global Carbapenem-Based Antibiotics Revenue, 2018-2023
4.2.2 By Type - Global Carbapenem-Based Antibiotics Revenue, 2024-2032
4.2.3 By Type - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Carbapenem-Based Antibiotics Market Size, 2022 & 2032
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.1.4 Hospital Pharmacies
5.2 By Application - Global Carbapenem-Based Antibiotics Revenue & Forecasts
5.2.1 By Application - Global Carbapenem-Based Antibiotics Revenue, 2018-2023
5.2.2 By Application - Global Carbapenem-Based Antibiotics Revenue, 2024-2032
5.2.3 By Application - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Carbapenem-Based Antibiotics Market Size, 2022 & 2032
6.2 By Region - Global Carbapenem-Based Antibiotics Revenue & Forecasts
6.2.1 By Region - Global Carbapenem-Based Antibiotics Revenue, 2018-2023
6.2.2 By Region - Global Carbapenem-Based Antibiotics Revenue, 2024-2032
6.2.3 By Region - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Carbapenem-Based Antibiotics Revenue, 2018-2032
6.3.2 US Carbapenem-Based Antibiotics Market Size, 2018-2032
6.3.3 Canada Carbapenem-Based Antibiotics Market Size, 2018-2032
6.3.4 Mexico Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Carbapenem-Based Antibiotics Revenue, 2018-2032
6.4.2 Germany Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.3 France Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.4 U.K. Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.5 Italy Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.6 Russia Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.7 Nordic Countries Carbapenem-Based Antibiotics Market Size, 2018-2032
6.4.8 Benelux Carbapenem-Based Antibiotics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Carbapenem-Based Antibiotics Revenue, 2018-2032
6.5.2 China Carbapenem-Based Antibiotics Market Size, 2018-2032
6.5.3 Japan Carbapenem-Based Antibiotics Market Size, 2018-2032
6.5.4 South Korea Carbapenem-Based Antibiotics Market Size, 2018-2032
6.5.5 Southeast Asia Carbapenem-Based Antibiotics Market Size, 2018-2032
6.5.6 India Carbapenem-Based Antibiotics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Carbapenem-Based Antibiotics Revenue, 2018-2032
6.6.2 Brazil Carbapenem-Based Antibiotics Market Size, 2018-2032
6.6.3 Argentina Carbapenem-Based Antibiotics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, 2018-2032
6.7.2 Turkey Carbapenem-Based Antibiotics Market Size, 2018-2032
6.7.3 Israel Carbapenem-Based Antibiotics Market Size, 2018-2032
6.7.4 Saudi Arabia Carbapenem-Based Antibiotics Market Size, 2018-2032
6.7.5 UAE Carbapenem-Based Antibiotics Market Size, 2018-2032
7 Carbapenem-Based Antibiotics Companies Profiles
7.1 ACS Dobfar S.p.A
7.1.1 ACS Dobfar S.p.A Company Summary
7.1.2 ACS Dobfar S.p.A Business Overview
7.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Major Product Offerings
7.1.4 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.1.5 ACS Dobfar S.p.A Key News & Latest Developments
7.2 Iterum Therapeutics plc
7.2.1 Iterum Therapeutics plc Company Summary
7.2.2 Iterum Therapeutics plc Business Overview
7.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Major Product Offerings
7.2.4 Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.2.5 Iterum Therapeutics plc Key News & Latest Developments
7.3 DAEWOONG PHARMACEUTICAL CO.,LTD
7.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Summary
7.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
7.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Major Product Offerings
7.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Key News & Latest Developments
7.4 Aurobindo Pharma Ltd
7.4.1 Aurobindo Pharma Ltd Company Summary
7.4.2 Aurobindo Pharma Ltd Business Overview
7.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Major Product Offerings
7.4.4 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.4.5 Aurobindo Pharma Ltd Key News & Latest Developments
7.5 Gland Pharma Limited
7.5.1 Gland Pharma Limited Company Summary
7.5.2 Gland Pharma Limited Business Overview
7.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Major Product Offerings
7.5.4 Gland Pharma Limited Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.5.5 Gland Pharma Limited Key News & Latest Developments
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Major Product Offerings
7.6.4 Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.6.5 Merck & Co., Inc. Key News & Latest Developments
7.7 Sumitomo Dainippon Pharma Co., Ltd.
7.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Summary
7.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
7.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Major Product Offerings
7.7.4 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.7.5 Sumitomo Dainippon Pharma Co., Ltd. Key News & Latest Developments
7.8 Savior Lifetec
7.8.1 Savior Lifetec Company Summary
7.8.2 Savior Lifetec Business Overview
7.8.3 Savior Lifetec Carbapenem-Based Antibiotics Major Product Offerings
7.8.4 Savior Lifetec Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.8.5 Savior Lifetec Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Major Product Offerings
7.9.4 Pfizer Inc. Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Spero Therapeutics
7.10.1 Spero Therapeutics Company Summary
7.10.2 Spero Therapeutics Business Overview
7.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Major Product Offerings
7.10.4 Spero Therapeutics Carbapenem-Based Antibiotics Revenue in Global Market (2018-2023)
7.10.5 Spero Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Carbapenem-Based Antibiotics Market Opportunities & Trends in Global Market
Table 2. Carbapenem-Based Antibiotics Market Drivers in Global Market
Table 3. Carbapenem-Based Antibiotics Market Restraints in Global Market
Table 4. Key Players of Carbapenem-Based Antibiotics in Global Market
Table 5. Top Carbapenem-Based Antibiotics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Carbapenem-Based Antibiotics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Carbapenem-Based Antibiotics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Carbapenem-Based Antibiotics Product Type
Table 9. List of Global Tier 1 Carbapenem-Based Antibiotics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carbapenem-Based Antibiotics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Carbapenem-Based Antibiotics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Carbapenem-Based Antibiotics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2024-2032
Table 30. ACS Dobfar S.p.A Company Summary
Table 31. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product Offerings
Table 32. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 33. ACS Dobfar S.p.A Key News & Latest Developments
Table 34. Iterum Therapeutics plc Company Summary
Table 35. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product Offerings
Table 36. Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 37. Iterum Therapeutics plc Key News & Latest Developments
Table 38. DAEWOONG PHARMACEUTICAL CO.,LTD Company Summary
Table 39. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product Offerings
Table 40. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 41. DAEWOONG PHARMACEUTICAL CO.,LTD Key News & Latest Developments
Table 42. Aurobindo Pharma Ltd Company Summary
Table 43. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product Offerings
Table 44. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 45. Aurobindo Pharma Ltd Key News & Latest Developments
Table 46. Gland Pharma Limited Company Summary
Table 47. Gland Pharma Limited Carbapenem-Based Antibiotics Product Offerings
Table 48. Gland Pharma Limited Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 49. Gland Pharma Limited Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. Carbapenem-Based Antibiotics Product Offerings
Table 52. Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. Sumitomo Dainippon Pharma Co., Ltd. Company Summary
Table 55. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product Offerings
Table 56. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 57. Sumitomo Dainippon Pharma Co., Ltd. Key News & Latest Developments
Table 58. Savior Lifetec Company Summary
Table 59. Savior Lifetec Carbapenem-Based Antibiotics Product Offerings
Table 60. Savior Lifetec Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 61. Savior Lifetec Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Carbapenem-Based Antibiotics Product Offerings
Table 64. Pfizer Inc. Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Spero Therapeutics Company Summary
Table 67. Spero Therapeutics Carbapenem-Based Antibiotics Product Offerings
Table 68. Spero Therapeutics Carbapenem-Based Antibiotics Revenue (US$, Mn) & (2018-2023)
Table 69. Spero Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Carbapenem-Based Antibiotics Segment by Type in 2022
Figure 2. Carbapenem-Based Antibiotics Segment by Application in 2022
Figure 3. Global Carbapenem-Based Antibiotics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Carbapenem-Based Antibiotics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Carbapenem-Based Antibiotics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2022
Figure 8. By Type - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 16. US Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 20. Germany Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 21. France Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 28. China Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 32. India Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 34. Brazil Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue Market Share, 2018-2032
Figure 37. Turkey Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2018-2032
Figure 41. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gland Pharma Limited Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Savior Lifetec Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Spero Therapeutics Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
